3,3-Diphenylpyrrolidine → HCID 67445716, Verbindung
Reaktionsgleichung
[Cl:1][C:2]1[CH:7]=[C:6]([F:8])[CH:5]=[CH:4][C:3]=1[CH:9]1[CH2:13][CH2:12][N:11]([CH2:14][C:15]([OH:17])=O)[C:10]1=[O:18].FC1C=CC(C2(C3C=CC(F)=CC=3)CCCN(CC(O)=O)C2=O)=CC=1.[F:44][C:45]([F:56])([F:55])[C:46]1[CH:47]=[C:48]2[C:52](=[CH:53][CH:54]=1)[CH2:51][NH:50][CH2:49]2.C1(C2(C3C=CC=CC=3)CCNC2)C=CC=CC=1>>[Cl:1][C:2]1[CH:7]=[C:6]([F:8])[CH:5]=[CH:4][C:3]=1[CH:9]1[CH2:13][CH2:12][N:11]([CH2:14][C:15](=[O:17])[N:50]2[CH2:49][C:48]3[C:52](=[CH:53][CH:54]=[C:46]([C:45]([F:44])([F:56])[F:55])[CH:47]=3)[CH2:51]2)[C:10]1=[O:18]Komponenten
5
Versuchsvorschrift
The title compound was prepared using the procedure described in Example 172 substituting 2-(3-(2-chloro-4-fluorophenyl)-2-oxopyrrolidin-1-yl)acetic acid from Example 268A for 2-(3,3-bis(4-fluorophenyl)-2-oxopiperidin-1-yl)acetic acid and 5-(trifluoromethyl)isoindoline for 3,3-diphenylpyrrolidine. 1H NMR (300 MHz, CDCl3) δ ppm 7.59 (t, J=9.9, 2H), 7.48-7.30 (m, 2H), 7.13 (dd, J=2.7, 8.5, 1H), 7.06-6.94 (m, 1H), 4.92 (d, J=19.6, 4H), 4.36 (d, J=16.2, 1H), 4.24-4.10 (m, 2H), 3.77-3.60 (m, 2H), 2.77-2.56 (m, 1H), 2.04 (dq, J=8.1, 13.4, 1H); MS (DCI) m/z 441.1 (M+H)+.
Quellen und Nachweise
- ORD-Eintrag
- ord-89001b5bf25048e79fbf6c25ff9a6419
- Quelldatensatz
- uspto-grants-2011_10
- Patentnummer
- US08044069B2
Notizen zur Reaktion
Wird geladen…